Pura Vida Investments’s ADMA Biologics ADMA Stock Holding History

Pura Vida Investments’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-477,800	Closed	-$1.81M	–	99
2019 Q1	$1.81M	Buy	+477,800	New	+$1.69M	0.26%	81

Other funds holding ADMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Pura Vida Investments's ADMA Position: Q1 2023 in Review

Pura Vida Investments sold out of ADMA Biologics (ADMA) in Q1 2023, closing a stake of 300,000 shares — an estimated $1.16M sold.

Pura Vida Investments first reported a position in ADMA in Q2 2016 and held it in 5 quarters. The position peaked at $3.55M in Q3 2018. 163 funds tracked by Wall St. Rank hold ADMA as of Q1 2023.

Pura Vida Investments reported no remaining ADMA Biologics position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 300,000 ADMA Biologics shares in Q1 2023, an estimated $1.16M.
Pura Vida Investments first reported a position in ADMA Biologics in Q2 2016 and held it in 5 quarters.
Pura Vida Investments's ADMA Biologics position peaked at $3.55M in Q3 2018.
163 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.